JP2008522989A5 - - Google Patents

Download PDF

Info

Publication number
JP2008522989A5
JP2008522989A5 JP2007544750A JP2007544750A JP2008522989A5 JP 2008522989 A5 JP2008522989 A5 JP 2008522989A5 JP 2007544750 A JP2007544750 A JP 2007544750A JP 2007544750 A JP2007544750 A JP 2007544750A JP 2008522989 A5 JP2008522989 A5 JP 2008522989A5
Authority
JP
Japan
Prior art keywords
dosage form
weight
form according
anionic
meth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007544750A
Other languages
English (en)
Japanese (ja)
Other versions
JP5578764B2 (ja
JP2008522989A (ja
Filing date
Publication date
Priority claimed from DE102004059792A external-priority patent/DE102004059792A1/de
Application filed filed Critical
Publication of JP2008522989A publication Critical patent/JP2008522989A/ja
Publication of JP2008522989A5 publication Critical patent/JP2008522989A5/ja
Application granted granted Critical
Publication of JP5578764B2 publication Critical patent/JP5578764B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007544750A 2004-12-10 2005-11-05 核酸包含粘膜接着性作用物質を含有する多粒子投与形、および前記投与形を生成する方法 Expired - Fee Related JP5578764B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004059792A DE102004059792A1 (de) 2004-12-10 2004-12-10 Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
DE102004059792.8 2004-12-10
PCT/EP2005/011864 WO2006061069A1 (de) 2004-12-10 2005-11-05 Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte nukleinsäure-wirkstoffe, sowie ein verfahren zur herstellung der arzneiform

Publications (3)

Publication Number Publication Date
JP2008522989A JP2008522989A (ja) 2008-07-03
JP2008522989A5 true JP2008522989A5 (https=) 2011-09-01
JP5578764B2 JP5578764B2 (ja) 2014-08-27

Family

ID=35709359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007544750A Expired - Fee Related JP5578764B2 (ja) 2004-12-10 2005-11-05 核酸包含粘膜接着性作用物質を含有する多粒子投与形、および前記投与形を生成する方法

Country Status (16)

Country Link
US (1) US8568778B2 (https=)
EP (1) EP1824457B1 (https=)
JP (1) JP5578764B2 (https=)
KR (1) KR101319773B1 (https=)
CN (1) CN101060835B (https=)
BR (1) BRPI0515815B8 (https=)
CA (1) CA2586597C (https=)
DE (1) DE102004059792A1 (https=)
ES (1) ES2569354T3 (https=)
HU (1) HUE028793T2 (https=)
IL (1) IL183753A (https=)
MX (1) MX2007006343A (https=)
PL (1) PL1824457T3 (https=)
SI (1) SI1824457T1 (https=)
TW (1) TW200635617A (https=)
WO (1) WO2006061069A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
WO2008002568A2 (en) * 2006-06-26 2008-01-03 Mutual Pharmaceutical Company, Inc. Active agent formulations, methods of making, and methods of use
WO2009012303A2 (en) * 2007-07-16 2009-01-22 Northeastern University Therapeutic stable nanoparticles
DE102008048729A1 (de) * 2008-09-24 2010-03-25 Add Technologies Ltd Advanced Drug Delivery Multipartikuläre Tabletten und Verfahren zur deren Herstellung
WO2011090725A2 (en) * 2009-12-29 2011-07-28 Impax Laboratories, Inc. Gastroretentive solid oral dosage forms with swellable hydrophilic polymer
WO2011103920A2 (en) 2010-02-25 2011-09-01 Evonik Röhm Gmbh Pharmaceutical or neutraceutical formulation
CN102250878B (zh) * 2011-06-03 2013-01-23 吉林大学 一种基于固相介质表面电荷的反转提取dna的方法
US9107851B2 (en) * 2012-10-15 2015-08-18 New Jersey Institute Of Technology Solventless mixing process for coating pharmaceutical ingredients
JP6912876B2 (ja) * 2016-10-06 2021-08-04 三洋化成工業株式会社 アクリル系医薬固形製剤用添加剤
WO2018170405A1 (en) * 2017-03-17 2018-09-20 Ohio State Innovation Foundation Nanoparticles for delivery of chemopreventive agents
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
DE102020002360A1 (de) * 2020-04-18 2021-10-21 Friedrich-Schiller-Universität Jena Nanopartikel enthaltend Komplexe aus Nukleinsäuren und kationischen Copolymeren, Verfahren zu deren Herstellung und deren Verwendung zum Gentransfer in Zellen
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
CN117120020A (zh) * 2021-03-30 2023-11-24 塞拉尼斯伊娃高性能聚合物公司 用于递送核酸包封颗粒的植入式医疗器件
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
JPWO2023249087A1 (https=) * 2022-06-24 2023-12-28
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW209174B (https=) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
EP0859857B1 (en) * 1995-10-25 2005-05-04 OctoPlus B.V. Cationic polyacrylates and poly(alkyl)acrylates or the corresponding acrylamides for use in synthetic transfection systems
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6730735B2 (en) 1997-07-03 2004-05-04 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Conjugate of polyethylene glycol and chitosan
ES2288152T3 (es) * 1999-08-09 2008-01-01 Dainippon Sumitomo Pharma Co., Ltd. Preparaciones solidas que contienen polvo de quitosano y procedimiento de produccion asociado.
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
AU2002319653A1 (en) * 2001-07-20 2003-03-03 Samir Mitragotri Method for oral drug delivery
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
DE10332160A1 (de) 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
DE10353186A1 (de) 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
DE10353196A1 (de) 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
US20040224019A1 (en) * 2004-03-03 2004-11-11 Adi Shefer Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
DE102004036437A1 (de) 2004-07-27 2006-03-23 Röhm GmbH & Co. KG Multipartikuläre Arzneiform für wenig lösliche Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
DE102006035549A1 (de) 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht

Similar Documents

Publication Publication Date Title
JP2008522989A5 (https=)
Yadav et al. Mucoadhesive polymers: means of improving the mucoadhesive properties of drug delivery system
JP5661281B2 (ja) 良好な水溶解性を有する作用物質のための作用物質の制御送達を有する医薬組成物
Roy et al. Polymers in mucoadhesive drug-delivery systems: A brief note
JP5167345B2 (ja) 薬剤を加速放出する腸溶コーティングを含む固体剤形
JP4140982B2 (ja) 薬剤形状物用被覆剤及び結合剤及び薬剤形状物
KR101454056B1 (ko) 에탄올의 영향에 대하여 내성을 가지는 비-오피오이드용 ph-의존성 조절 방출 제약 조성물
CN102006863A (zh) 膜组合物
JPH02240017A (ja) 放出性が改良されたジエムフイブロジル組成物
JP2005514386A5 (https=)
CN1446083A (zh) 具有活性物质可控性释放的涂覆药物剂型
RU2013111605A (ru) Резистентная к действию желудочного сока фармацевтическая или нутрицевтическая композиция, содержащая одну или более солей альгиновой кислоты
US7531612B2 (en) pH sensitive polymer and process for preparation thereof
CN1044590A (zh) 持续释放二甲苯氧庚酸组合物的制备方法
JP2018521030A5 (https=)
CN114845700A (zh) Otf的可溶性背衬层
US20060134054A1 (en) Polymer composition for pH dependent dissolution behavior and process for preparation thereof
JP5534643B2 (ja) 多層剤形
JP2010504318A5 (https=)
Bromberg Intelligent polyelectrolytes and gels in oral drug delivery
CN101103055A (zh) 经部分中和的阴离子(甲基)丙烯酸酯共聚物
JP2007509903A5 (https=)
AU2003288706B2 (en) pH sensitive polymer and process for preparation thereof
Animesh et al. Applicability and approaches of (Meth) acrylate copolymers (Eudragits) in novel drug delivery systems
JP2002536318A5 (https=)